Back

First clinical evaluation of subcutaneous implantable cardiac defibrillator in Brugada patients

1 September 2019 (15:45 - 16:35)
Organised by:
Congress Presentation Part of: News on the ICD front, the transveneous, the subcutaneous and the wearable Implantable Cardioverter-Defibrillator (ICD) ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Vincent Probst

University Hospital of Nantes, Nantes (France)

5 More presentations in this session

Presentation thumbnail
Sudden cardiac death in non-ischemic systolic heart failure : do we only need LVEF to decide ICD implantation ?
Doctor T. Mercier (Valenciennes, FR)
Abstract
Presentation thumbnail
Utility of cardiovascular implantable electronic device (CIED)-derived patient activity, a novel digital biomarker, to predict inappropriate therapy
Associate Professor V. Kutyifa (Rochester, US)
Abstract
Presentation thumbnail
Risk of life-threatening ventricular tachyarrhythmia events in diabetes patients with higher ejection fraction in MADIT-CRT
Professor I. Goldenberg (Rochester, US)
Abstract Slides
Presentation thumbnail
Incidence and predictors of alarms in patients with wearable cardioverter defibrillator (WCD) - results of the Austrian WCD Registry
Doctor U. Rohrer (Graz, AT)
Abstract
Presentation thumbnail
Inadequate heart rate control begets sustained ventricular arrhythmias in a large cohort of women
Doctor J. Erath (Frankfurt, DE)
Abstract Slides

Access the full session

Session thumbnail
News on the ICD front, the transveneous, the subcutaneous and the wearable

The Event

Event poster

ESC Congress 2019

1 September 2019 15:45 CET
You may be interested in
thumbnail
Congress Session
Debate on primary prevention in ICD therapy
thumbnail
Congress Session
Implantable cardioverter defibrillator therapy
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources